Ask Questions About Clinical Trials (ASQ - CT): An Implementation Trial of a Communication Intervention to Improve Patient-Provider Communication About Clinical Trials and Provider Invitations to Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 293
- 试验地点
- 8
- 主要终点
- Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale
研究概览
简要总结
The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > or equal to 18 years
- •Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment
- •Potentially eligible for a clinical trial
- •Speak and read English well enough to be able to understand consent documents and complete surveys
排除标准
- •Not able to complete study documents on their own physically or cognitively
研究组 & 干预措施
Ask Questions about Clinical Trials (ASQ-CT) Brochure
Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure
干预措施: Ask Questions about Clinical Trials brochure (Behavioral)
结局指标
主要结局
Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale
时间窗: From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)
Improvement of self-efficacy in managing patient-providers interactions between baseline (Time 1) and pre-clinic visit (Time 2). Measured using scale of 1-5 where a higher score is equal to a better outcome
次要结局
- Reach - Number and Proportion(At start of Participation)
- Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale(From Pre-Clinic (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months.)
- Effectiveness - Knowledge - Quantitative Scale(From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2))
- Effectiveness - Knowledge - Quantitative Scale(From Pre-Clinic Visit (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months)
- Effectiveness - Trust - Quantitative Scale(From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2))
- Effectiveness - Trust - Quantitative Scale(From Pre-Clinic Visit (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months)
- Effectiveness - distress - Quantitative Scale(From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2))
- Effectiveness - distress - Quantitative Scale(From Pre-Clinic Visit (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months)
- Adoption - Number and Proportion(At start of Participation)
- Implementation of the Intervention(From Baseline (Time 1) to up to 3 months)
研究者
Lauren Hamel
Principal Investigator
Barbara Ann Karmanos Cancer Institute